Optimal target international normalized ratio for patients with mechanical heart valves [3]

Journal of the American College of Cardiology

Volumn 44, Issue 5, 2004, Pages 1142-1143

  Takkenberg, Johanna J M ^a   Puvimanasinghe, John P A ^a   Van Herwerden, Lex A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K;

AORTA VALVE PROSTHESIS; BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; HEART VALVE PROSTHESIS; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LETTER; META ANALYSIS; MITRAL VALVE PROSTHESIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; THROMBOEMBOLISM; THROMBOSIS;

AORTIC VALVE; HEART DISEASES; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE; THROMBOEMBOLISM; VITAMIN K;

EID: 4444307272     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.06.010     Document Type: Letter

References (4)

1. R. Vink, R.A. Kraaijenhagen, B.A Hutten The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis J Am Coll Cardiol 42 2003 2042 2048
2. Huth C, Friedl A, Rost A. Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA database (GELIA 4). Eur Heart J Suppl 2001;Suppl Q:Q33-8.
3. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588.
4. J.J. Takkenberg, J.P. Puvimanasinghe, G.L. Grunkemeier Simulation models to predict outcome after aortic valve replacement Ann Thorac Surg 75 2003 1372 1376